StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) stock

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)

Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –

Earnings

Intuitive Surgical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 13, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$3.05B
+21.5% on a year earlier
Non-GAAP net income per share attributable to Intuitive Surgical, Inc. - diluted, Q3 FY2026
$3.00
$2.40 a year earlier
Latest guidance
Issued
Oct 20, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Intuitive Surgical's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Jan 13, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 20, 2026after the close$3.05B+21.5%$1.49$3.00Release
Q2 FY2026ended Jun 30, 2026Jul 16, 2026after the close$2.89B+18.4%$2.29$2.80Release
Q1 FY2026ended Mar 31, 2026Apr 21, 2026after the close$2.77B+23.1%$2.28$2.50Release
Q4 FY2025ended Dec 31, 2025Jan 14, 2026before the open$2.87B+19.1%––Release
Q3 FY2025ended Sep 30, 2025Oct 21, 2025after the close$2.51B+23.0%$1.95$2.40Release
Q2 FY2025ended Jun 30, 2025Jul 22, 2025after the close$2.44B+21.4%$1.81$2.19Release
Q1 FY2025ended Mar 31, 2025Apr 22, 2025after the close$2.25B+19.0%$1.92$1.81Release
Q4 FY2024ended Dec 31, 2024Jan 15, 2025before the open$2.41B+24.9%––Release
Q3 FY2024ended Sep 30, 2024Oct 17, 2024after the close$2.04B+17.2%$1.56$1.84Release
Q2 FY2024ended Jun 30, 2024Jul 18, 2024after the close$2.01B+14.2%$1.46$1.78Release
Q1 FY2024ended Mar 31, 2024Apr 18, 2024after the close$1.89B+11.2%$1.51$1.50Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Intuitive Surgical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Non-GAAP* gross profit marginnon-GAAPFY202668.7% – 69.3%–NewOct 20, 2026
Non-GAAP* gross profit marginnon-GAAPFY202668% – 69%67.5% – 68.5%RaisedJul 16, 2026
Non-GAAP* operating expense growthnon-GAAPFY2026+11% – +13%–NewOct 20, 2026
Non-GAAP* operating expense growthnon-GAAPFY2026+11% – +13%+11% – +14%LoweredJul 16, 2026
Worldwide da Vinci procedure growthFY2026+14% – +15%–NewOct 20, 2026
Worldwide da Vinci procedure growthFY2026+13.5% – +15.5%+13.5% – +15.5%ReaffirmedJul 16, 2026
worldwide da Vinci proceduresFY2026+13% – +15%–NewJan 14, 2026

Guidance history

Every forecast Intuitive Surgical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 20, 2026Non-GAAP* gross profit marginFY202668.7% – 69.3%New
Oct 20, 2026Worldwide da Vinci procedure growthFY2026+14% – +15%New
Oct 20, 2026Non-GAAP* operating expense growthFY2026+11% – +13%New
Jul 16, 2026Non-GAAP* gross profit marginFY202668% – 69%Raised
Jul 16, 2026Worldwide da Vinci procedure growthFY2026+13.5% – +15.5%Reaffirmed
Jul 16, 2026Non-GAAP* operating expense growthFY2026+11% – +13%Lowered
Apr 21, 2026Non-GAAP* gross profit marginFY202667.5% – 68.5%New
Apr 21, 2026Worldwide da Vinci procedure growthFY2026+13.5% – +15.5%Raised
Apr 21, 2026Non-GAAP* operating expense growthFY2026+11% – +14%New
Jan 14, 2026worldwide da Vinci proceduresFY2026+13% – +15%New
Oct 21, 2025Non-GAAP* gross profit marginFY202567% – 67.5%Raised
Oct 21, 2025Worldwide da Vinci procedure growthFY2025+17% – +17.5%Raised
Oct 21, 2025Non-GAAP* operating expense growthFY2025+11% – +13%Narrowed
Jul 22, 2025Non-GAAP* gross profit marginFY202566% – 67%New
Jul 22, 2025Worldwide da Vinci procedure growthFY2025+15.5% – +17%New
Jul 22, 2025Non-GAAP* operating expense growthFY2025+10% – +14%New
Apr 22, 2025Non-GAAP* gross profit marginFY202565% – 66.5%New
Apr 22, 2025Worldwide da Vinci procedure growthFY2025+15% – +17%Raised
Apr 22, 2025Non-GAAP* operating expense growthFY2025+10% – +14%New
Jan 15, 2025worldwide da Vinci proceduresFY2025+13% – +16%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Intuitive Surgical filed with the SEC as exhibits to Form 8-K or 6-K

  1. INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS
    Results
  2. INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS
    Results
  3. INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS
    Results
  4. Intuitive Expands Investment and Footprint in Europe
    News
  5. INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS
    Results
  6. FOURTH QUARTER AND FULL YEAR 2025 RESULTS
    Results
  7. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics
    Results
  8. INTUITIVE ANNOUNCES THIRD QUARTER EARNINGS
    Results
  9. INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS
    Results
  10. Intuitive Announces CEO Transition Effective July 1, 2025
    Update
  11. INTUITIVE ANNOUNCES FIRST QUARTER EARNINGS
    Results
  12. INTUITIVE ANNOUNCES FOURTH QUARTER EARNINGS
    Results
  13. Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal
    Results
  14. FOURTH QUARTER AND FULL YEAR 2024 RESULTS
    Results
  15. Unaudited Preliminary Quarterly and Annual Revenue Data and Metrics
    Results